The results showed that there was no significant difference in IL-6 and IL-10 between the two groups, while COVID-19 patients had lower levels of IL-2 and higher levels of CD3+CD4+ T cells and CD19+ B cells. This evidence concerns the gene CD4 and COVID-19.